Pharmaceutical companies by P/E ratio

Share price divided by the last twelve months' earnings per share: how many years of today's profit the price pays for. A company making a loss has none.

Takeda Pharmaceutical leads the 33 pharmaceutical companies ranked by P/E ratio, at 304, ahead of Merck & Co (139) and Ligand Pharmaceuticals (120). Figures as of 18 Nov 2026, 21:41 UTC, from Yahoo Finance quotes.

Key facts

Companies ranked
33
First
Takeda Pharmaceutical304
Median
40.1
Combined market value
ZAR 87.39T
Countries
10
Not ranked
28no P/E ratio on file

Market values as of .

All countries
All sectors
Pharmaceuticals
ZAR
Clear filters
Pharmaceutical companies by P/E ratio
#CompanyP/E ↓Market capPriceToday1 yearPrice, 30 daysCountry
1Takeda PharmaceuticalTAK · Health Care304ZAR 1.17TZAR 367.43 1.71% down 54% up Japan
2Merck & CoMRK · Health Care139ZAR 5.87TZAR 2,380.08 3.90% down 51% up United States
3Ligand PharmaceuticalsLGND · Health Care120ZAR 103.2BZAR 5,160.07 1.67% up 43% up United States
4TG TherapeuticsTGTX · Health Care98.7ZAR 172.6BZAR 1,142.19 5.44% up 107% up United States
5Teva Pharmaceutical IndustriesTEVA · Health Care98.2ZAR 851.2BZAR 729.50 0.92% down 74% up Israel
6Jazz PharmaceuticalsJAZZ · Health Care73.3ZAR 274.7BZAR 4,280.10 2.93% up 37% up Ireland
7Kiniksa Pharmaceuticals InternationalKNSA · Health Care72.0ZAR 129BZAR 1,641.94 0.06% down 126% up United Kingdom
8Amneal PharmaceuticalsAMRX · Health Care54.7ZAR 131.7BZAR 377.97 3.60% up 83% up United States
9BeOne MedicinesONC · Health Care51.7ZAR 796.4BZAR 6,971.99 2.34% down 17% up Switzerland
10Corcept TherapeuticsCORT · Health Care51.0ZAR 128.2BZAR 1,171.04 3.25% down 8% down United States
11AbbVieABBV · Health Care49.1ZAR 8.73TZAR 4,940.68 2.33% down 26% up United States
12Royalty PharmaRPRX · Health Care44.9ZAR 682.1BZAR 1,186.24 0.01% down 78% up United States
13Eli LillyLLY · Health Care44.9ZAR 21.28TZAR 23,886.31 2.32% down 35% up United States
14GenmabGMAB · Health Care43.6ZAR 542.9BZAR 880.48 1.91% down 70% up Denmark
15Dr. Reddy's LaboratoriesRDY · Health Care41.6ZAR 215.7BZAR 258.77 1.28% up 5% up India
16Johnson & JohnsonJNJ · Health Care41.4ZAR 11.34TZAR 4,710.76 2.15% down 38% up United States
17PfizerPFE · Health Care40.1ZAR 2.76TZAR 484.72 1.44% down 14% up United States
18Abbott LaboratoriesABT · Health Care39.0ZAR 3.13TZAR 1,804.84 0.22% down 17% down United States
19Vertex PharmaceuticalsVRTX · Health Care34.5ZAR 2.35TZAR 9,266.91 0.42% up 27% up United States
20NovartisNVS · Health Care29.6ZAR 5.06TZAR 2,681.18 2.46% down 25% up Switzerland
21Protagonist TherapeuticsPTGX · Health Care26.9ZAR 143.4BZAR 2,196.63 2.00% up 46% up United States
22AstraZenecaAZN · Health Care25.3ZAR 4.79TZAR 3,087.99 1.93% down 2% up United Kingdom
23SanofiSNY · Health Care23.4ZAR 1.95TZAR 813.97 0.86% down 4% down France
24United TherapeuticsUTHR · Health Care21.8ZAR 424.7BZAR 9,973.26 1.16% down 23% up United States
25Regeneron PharmaceuticalsREGN · Health Care20.9ZAR 1.69TZAR 16,333.56 1.28% down 36% up United States
26Ascendis PharmaASND · Health Care17.8ZAR 306.3BZAR 4,669.82 0.32% down 28% up Denmark
27GSKGSK · Health Care16.9ZAR 1.68TZAR 839.20 1.34% down 6% up United Kingdom
28ZoetisZTS · Health Care14.6ZAR 600.6BZAR 1,478.18 2.50% up 29% down United States
29Bristol-Myers SquibbBMY · Health Care13.2ZAR 2.1TZAR 1,028.87 2.92% down 34% up United States
30GrifolsGRFS · Health Care10.2ZAR 99.6BZAR 146.32 1.85% down 1% up Spain
31Novo NordiskNVO · Health Care10.0ZAR 3TZAR 681.13 3.12% down 17% down Denmark
32Alnylam PharmaceuticalsALNY · Health Care7.5ZAR 345.7BZAR 2,580.81 4.54% down 66% down United States
33Edgewise TherapeuticsEWTX · Health Care4.9ZAR 78.2BZAR 714.65 1.59% down 88% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Sums are converted from US dollars at today's exchange rate (1 USD = 17.2745 ZAR). 28 companies have no P/E ratio on file and are not ranked here.

Questions and answers

Which pharmaceutical companies rank first by P/E ratio?

Takeda Pharmaceutical (304), Merck & Co (139) and Ligand Pharmaceuticals (120) are the top three of the 33 pharmaceutical companies ranked by P/E ratio as of 18 Nov 2026, 21:41 UTC.

How many pharmaceutical companies are in this ranking?

33 are ranked by P/E ratio. 28 more have no P/E ratio on file and are left out rather than ranked at zero.

What are these pharmaceutical companies worth together?

The 33 pharmaceutical companies ranked by P/E ratio have a combined market value of ZAR 87.39T as of 18 Nov 2026, 21:41 UTC.

What does ranking by P/E ratio measure?

Share price divided by the last twelve months' earnings per share: how many years of today's profit the price pays for. A company making a loss has none.

Cite this page

Funkfolio, “Pharmaceutical companies by P/E ratio”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=pe-ratio

Underlying data: Yahoo Finance; SEC EDGAR.